BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 33774512)

  • 1. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male gender and kidney illness are associated with an increased risk of severe laboratory-confirmed coronavirus disease.
    Murillo-Zamora E; Trujillo X; Huerta M; Ríos-Silva M; Mendoza-Cano O
    BMC Infect Dis; 2020 Sep; 20(1):674. PubMed ID: 32938419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
    Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
    Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?
    Tuan J; Spichler-Moffarah A; Ogbuagu O
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data.
    Bello-Chavolla OY; Antonio-Villa NE; Fernández-Chirino L; Guerra EC; Fermín-Martínez CA; Márquez-Salinas A; Vargas-Vázquez A; Bahena-López JP
    PLoS One; 2021; 16(8):e0256447. PubMed ID: 34464393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
    Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
    Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
    Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
    Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
    Kubale J; Balmaseda A; Frutos AM; Sanchez N; Plazaola M; Ojeda S; Saborio S; Lopez R; Barilla C; Vasquez G; Moreira H; Gajewski A; Campredon L; Maier HE; Chowdhury M; Cerpas C; Harris E; Kuan G; Gordon A
    JAMA Netw Open; 2022 Jun; 5(6):e2218794. PubMed ID: 35759261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020.
    Amorim MR; Souza WM; Barros ACG; Toledo-Teixeira DA; Dos-Santos KB; Simeoni CL; Parise PL; Vieira A; Forato J; Claro IM; Mofatto LS; Barbosa PP; Brunetti NS; França ESS; Pedroso GA; Carvalho BFN; Zaccariotto TR; Krywacz KCS; Vieira AS; Mori MA; Farias AS; Pavan MHP; Bachur LF; Cardoso LGO; Spilki FR; Sabino EC; Faria NR; Santos MNN; Angerami R; Leme PAF; Schreiber A; Moretti ML; Granja F; Proenca-Modena JL
    Emerg Infect Dis; 2021; 27(6):1737-1740. PubMed ID: 33871331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection.
    Maier HE; Kuan G; Saborio S; Carrillo FAB; Plazaola M; Barilla C; Sanchez N; Lopez R; Smith M; Kubale J; Ojeda S; Zuniga-Moya JC; Carlson B; Lopez B; Gajewski AM; Chowdhury M; Harris E; Balmaseda A; Gordon A
    Clin Infect Dis; 2022 Aug; 75(1):e257-e266. PubMed ID: 34411230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis.
    Deng J; Ma Y; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.